Dow Up0.51% Nasdaq Up0.24%

Alexion Pharmaceuticals, Inc. (ALXN)

191.02 Nov 21, 4:00PM EST
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income 252,895   254,822   175,315  
Operating Activities, Cash Flows Provided By or Used In
Depreciation31,928  23,887  17,592  
Adjustments To Net Income208,601  153,185  94,360  
Changes In Accounts Receivables(116,439)(72,870)(78,778)
Changes In Liabilities160,117  74,895  94,814  
Changes In Inventories126  (6,265)(12,179)
Changes In Other Operating Activities(39,879)(17,041)(21,040)
Total Cash Flow From Operating Activities 497,349   410,613   270,084  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(29,329)(21,846)(21,982)
Investments(988,497) -  94,458  
Other Cash flows from Investing Activities(9,315)(605,739)(106,193)
Total Cash Flows From Investing Activities (1,027,141) (627,585) (33,717)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock5,145  517,097  35,765  
Net Borrowings(36,000)149,000   -  
Other Cash Flows from Financing Activities(3,220)(765)(731)
Total Cash Flows From Financing Activities 71,639   666,376   39,050  
Effect Of Exchange Rate Changes(1,491)(768)(1,697)
Change In Cash and Cash Equivalents (459,644) 448,636   273,720  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.